Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection

Objective: Given the urgent need for strategies to minimize the damage caused by this pandemic, this study performed a randomized, double-blind phase 2 study to assess the safety of the effectiveness of chloroquine (CQ), hydroxychloroquine (HCQ) or ivermectin in severe forms of COVID-19, in addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Galan, Luis Enrique Bermejo, dos Santos, Nayara Melo, Asato, Mauro Shosuka, Araújo, Jucineide Vieira, de Lima Moreira, Adriana, Araújo, Aléxia Mahara Marques, Paiva, Artur Diogenes Pinheiro, Portella, Diego Guilherme Santos, Marques, Frank Silas Saldanha, Silva, Gabriel Melo Alexandre, de Sousa Resende, Joana, Tizolim, Marycassiely Rodrigues, Santos, Poliana Lucenados, Buttenbender, Steffi Ferreira, de Andrade, Stephanye Batista, Carbonell, Roberto Carlos Cruz, Da Rocha, Juliana Gomes, de Souza, Ruy Guilherme Silveira, da Fonseca, Allex Jardim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938655/
https://www.ncbi.nlm.nih.gov/pubmed/33682640
http://dx.doi.org/10.1080/20477724.2021.1890887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938655/
https://www.ncbi.nlm.nih.gov/pubmed/33682640
http://dx.doi.org/10.1080/20477724.2021.1890887

Ejemplares similares